Clinical trial
OPTIMAL - Individualized Titration of Biologics in Severe Asthma
NCT04648761 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OPTIMAL - Individualized Titration of Biologics in Severe Asthma
- Lead sponsor
- Bispebjerg Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- October 1, 2023
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.